Advanced search
Publication Cover
Blood and Lymphatic Cancer: Targets and Therapy Volume 8, 2018 - Issue
Submit an article Journal homepage
554
Views
55
CrossRef citations to date
0
Altmetric
Review

Plasmablastic lymphoma: current perspectives

Andres Lopez1 Lymphoma Unit, Department of Hematology, Vall d’Hebron University Hospital, Barcelona, Spain, [email protected]Correspondence[email protected]
&
Pau Abrisqueta2 Department of Hematology, Vall d’Hebron Institute of Oncology, Vall d’Hebron University Hospital, Barcelona, Spain
Pages 63-70 | Published online: 04 Oct 2018

Figures & data

Figure 1 New therapeutic targets in PbL.

Notes: Novel monoclonal antibodies and promising agents directed to inhibit different signaling pathways in PbL are represented.
Abbreviations: EBV, Epstein–Barr virus; PbL, plasmablastic lymphoma.
Figure 1 New therapeutic targets in PbL.
 

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.